Malaria, other vectorborne and parasitic diseases

Third Meeting of the Pacific Malaria Drug Resistance Monitoring Network

16 to 17 June - Manila, Philippines

Background

The Pacific Malaria Drug Resistance Monitoring Network was established in 2011 to expand and support national malaria drug resistance monitoring activities in the Pacific. The network forms part of the WHO Emergency Response to Artemisinin Resistance (ERAR), aiming to facilitate the early detection and prevention of artemisinin resistance in the Pacific (already detected in the Greater Mekong Subregion) based on implementation of routine high-quality surveillance of malaria drug efficacy in sentinel sites by national malaria control programmes. The Pacific network comprises the following countries: Malaysia, Papua New Guinea, the Philippines, the Republic of Korea, Solomon Islands and Vanuatu in the Western Pacific Region; and Indonesia and Timor Leste in the South-East Asia Region.

This third, biregional meeting of the Pacific Malaria Drug Resistance Monitoring Network aims to review latest Pacific data and discuss implications for national treatment guidelines, and jointly plan the way forward for countries and the network. The meeting will be held on 16-17 June 2014 in Manila, Philippines, and will bring together representatives of the national malaria programmes of eight Pacific countries of the WHO SouthEast Asia and Western Pacific Regions and relevant stakeholders.

Objectives:

  • To assess antimalarial drug efficacy data generated in countries and existing monitoring systems, the appropriateness of current national malaria treatment policies based on data presented, and identify key issues and gaps;
  • To review and update country plans for antimalarial drug efficacy monitoring for the next two years; and
  • To discuss and further develop the Pacific Malaria Drug Resistance Monitoring Network plan of action, including partner cooperation, resource mobilization and linkages with other networks.
Share